Lifecore Biomedical
LFCR
LFCR
75 hedge funds and large institutions have $119M invested in Lifecore Biomedical in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 78 → 75 (-3)
3.95% less ownership
Funds ownership: 70.57% → 66.62% (-4%)
13% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 23
Holders
75
Holding in Top 10
4
Calls
$537K
Puts
$209K
Top Buyers
| 1 | +$5.77M | |
| 2 | +$1.51M | |
| 3 | +$1.08M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$828K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$623K |
Top Sellers
| 1 | -$7.59M | |
| 2 | -$1.87M | |
| 3 | -$1.64M | |
| 4 |
TAM
Tocqueville Asset Management
New York
|
-$1.18M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$884K |